• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用粘膜粘附聚合物和PEG-6-硬脂酸酯作为亲水性蜡质粘合剂制备和评价卡维地洛口腔崩解片

Formulation and evaluation of carvedilol melt-in-mouth tablet using mucoadhesive polymer and PEG-6-stearate as hydrophilic waxy binder.

作者信息

Dangi Amish Ashvinkumar, Zalodiya Prakash Bhikhabhai

机构信息

Department of Pharmaceutics, Suresh Gyan Vihar University, Jaipur, Rajasthan, India.

出版信息

Int J Pharm Investig. 2012 Oct;2(4):183-8. doi: 10.4103/2230-973X.106989.

DOI:10.4103/2230-973X.106989
PMID:23580934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3618634/
Abstract

PURPOSE

The demand for melt-in-mouth tablets (MMTs) has been rapidly growing during the last decade, especially for the elderly and children who have swallowing difficulties, to avoid first-pass metabolism and quick drug entry into the systemic circulation.

MATERIALS AND METHODS

In this work, a new approach has been tried to prepare MMTs using a hydrophilic waxy binder [polyethylene glycol (PEG)-6-stearate]. Carvedilol MMTs were prepared by direct compression method using different mucoadhesive polymers such as hydroxypropyl methylcellulose (HPMC), chitosan, and sodium carboxymethyl cellulose (Na-CMC) at various concentrations (range: 0.5-5%) to reduce the flushing action of saliva and to increase mucosal absorption. All the formulations were evaluated for various physiochemical parameters, and the formulations containing the maximum amount of polymer (F4, F7, and F10) were selected for further stability study.

RESULTS

The deaggregation time of the tablets was found to be rapid, and the dissolution test revealed that carvedilol was dissolved from the formulation within the compendia limits. This data confirmed that the polymer concentration (0.5-5%) was within acceptable limits. It was also concluded that avicel PH101, pearlitol SD 200, and croscarmellose sodium (CCS) were the appropriate excipients and formulated in the right proportion.

CONCLUSION

As a result, mouth dissolving administration of carvedilol formulated with appropriate excipients and especially with chitosan seems a promising alternative to traditional routes.

摘要

目的

在过去十年中,口腔崩解片(MMT)的需求迅速增长,特别是对于有吞咽困难的老年人和儿童,以避免首过代谢并使药物快速进入体循环。

材料与方法

在这项工作中,尝试了一种新方法,即使用亲水性蜡质粘合剂[聚乙二醇(PEG)-6-硬脂酸酯]制备口腔崩解片。采用直接压片法,使用不同浓度(范围:0.5 - 5%)的不同粘膜粘附聚合物,如羟丙基甲基纤维素(HPMC)、壳聚糖和羧甲基纤维素钠(Na-CMC)制备卡维地洛口腔崩解片,以减少唾液的冲洗作用并增加粘膜吸收。对所有制剂进行各种理化参数评估,并选择含有最大聚合物量的制剂(F4、F7和F10)进行进一步的稳定性研究。

结果

发现片剂的崩解时间很快,溶出度试验表明卡维地洛从制剂中溶出符合药典规定。该数据证实聚合物浓度(0.5 - 5%)在可接受范围内。还得出结论,微晶纤维素PH101、山梨醇SD 200和交联羧甲基纤维素钠(CCS)是合适的辅料,且配比正确。

结论

因此,用合适辅料特别是壳聚糖配制的卡维地洛口腔崩解给药似乎是传统给药途径的一个有前景的替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af46/3618634/f2137c329f5b/IJPI-2-183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af46/3618634/cc4b033ec664/IJPI-2-183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af46/3618634/f2137c329f5b/IJPI-2-183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af46/3618634/cc4b033ec664/IJPI-2-183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af46/3618634/f2137c329f5b/IJPI-2-183-g005.jpg

相似文献

1
Formulation and evaluation of carvedilol melt-in-mouth tablet using mucoadhesive polymer and PEG-6-stearate as hydrophilic waxy binder.使用粘膜粘附聚合物和PEG-6-硬脂酸酯作为亲水性蜡质粘合剂制备和评价卡维地洛口腔崩解片
Int J Pharm Investig. 2012 Oct;2(4):183-8. doi: 10.4103/2230-973X.106989.
2
Formulation of zolmitriptan sublingual tablets prepared by direct compression with different polymers: in vitro and in vivo evaluation.采用不同聚合物直接压片制备佐米曲普坦舌下片的配方研究:体外和体内评价。
Eur J Pharm Biopharm. 2011 Aug;78(3):499-505. doi: 10.1016/j.ejpb.2011.02.014. Epub 2011 Feb 23.
3
The preparation of orally disintegrating tablets using a hydrophilic waxy binder.使用亲水性蜡质粘合剂制备口腔崩解片。
Int J Pharm. 2004 Jul 8;278(2):423-33. doi: 10.1016/j.ijpharm.2004.03.023.
4
Development and evaluation of hydrophilic colloid matrix of famotidine tablets.法莫替丁片剂亲水胶体骨架的研制与评价。
AAPS PharmSciTech. 2010 Jun;11(2):708-18. doi: 10.1208/s12249-010-9427-7. Epub 2010 Apr 27.
5
Studies on formulation development of mouth dissolving tablets of Carvedilol.卡维地洛口腔崩解片的处方开发研究
Hindustan Antibiot Bull. 2007;49-50(1-4):21-8.
6
Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.采用质量源于设计方法通过热熔挤出制备无定形固体分散体片剂配方的研究
AAPS PharmSciTech. 2016 Feb;17(1):214-32. doi: 10.1208/s12249-015-0472-0. Epub 2016 Jan 12.
7
Development of Sustained Release System Based on High Water-Absorbable Gel Formation Using Croscarmellose Sodium, Alkaline Excipients and HPMC (ACSH SR System); Novel Application of Croscarmellose Sodium as a Gel Former.基于交联羧甲纤维素钠、碱性赋形剂和 HPMC 形成高吸水性凝胶的缓释系统的开发(ACSH SR 系统);交联羧甲纤维素钠作为凝胶形成剂的新应用。
Pharm Res. 2023 Dec;40(12):3073-3086. doi: 10.1007/s11095-023-03630-w. Epub 2023 Nov 14.
8
Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.用于口腔崩解片制剂的卡维地洛、β-环糊精和柠檬酸的三元络合作用
Acta Pharm. 2009 Jun;59(2):121-32. doi: 10.2478/v10007-009-0001-3.
9
Nano and Microparticulate Chitosan Based System for Formulation of Carvedilol Rapid Melt Tablet.基于纳米和微粒壳聚糖的卡维地洛速溶片制剂系统
Adv Pharm Bull. 2015 Jun;5(2):169-79. doi: 10.15171/apb.2015.024. Epub 2015 Jun 1.
10
Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation.粘膜粘附给药系统。I. 用于口腔片剂制剂的粘膜粘附聚合物的评价。
Drug Dev Ind Pharm. 2004;30(9):985-93. doi: 10.1081/ddc-200037245.

本文引用的文献

1
A new formulation for orally disintegrating tablets using a suspension spray-coating method.采用混悬液喷雾包衣法的新型口腔崩解片配方。
Int J Pharm. 2009 Dec 1;382(1-2):80-7. doi: 10.1016/j.ijpharm.2009.08.010. Epub 2009 Aug 15.
2
In vitro and in vivo evaluation of nimesulide lyophilized orally disintegrating tablets.尼美舒利冻干口腔崩解片的体内外评价。
Eur J Pharm Biopharm. 2009 Sep;73(1):162-71. doi: 10.1016/j.ejpb.2009.04.005. Epub 2009 May 4.
3
Effect of powder characteristics on oral tablet disintegration.粉末特性对口服片剂崩解的影响。
Int J Pharm. 2009 Jan 5;365(1-2):116-20. doi: 10.1016/j.ijpharm.2008.08.031. Epub 2008 Aug 29.
4
Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.崩解促进剂、润滑剂及湿度处理对优化速崩片的影响
Int J Pharm. 2009 Jan 5;365(1-2):4-11. doi: 10.1016/j.ijpharm.2008.08.010. Epub 2008 Aug 22.
5
Fast dissolving films made of maltodextrins.由麦芽糊精制成的速溶薄膜。
Eur J Pharm Biopharm. 2008 Nov;70(3):895-900. doi: 10.1016/j.ejpb.2008.06.032. Epub 2008 Jul 10.
6
Fast dispersible/slow releasing ibuprofen tablets.速溶/缓释布洛芬片
Eur J Pharm Biopharm. 2008 May;69(1):335-41. doi: 10.1016/j.ejpb.2007.11.011. Epub 2007 Nov 28.
7
Effect of preparation method on properties of orally disintegrating tablets made by phase transition.制备方法对相变法制备的口腔崩解片性质的影响。
Int J Pharm. 2008 May 1;355(1-2):87-92. doi: 10.1016/j.ijpharm.2007.11.046. Epub 2007 Dec 4.
8
Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.含甘氨酸和羧甲基纤维素的速崩片的评估
Int J Pharm. 2006 Mar 9;310(1-2):101-9. doi: 10.1016/j.ijpharm.2005.11.041. Epub 2006 Jan 23.
9
Formulation design of a novel fast-disintegrating tablet.一种新型速崩片的处方设计
Int J Pharm. 2005 Dec 8;306(1-2):83-90. doi: 10.1016/j.ijpharm.2005.09.009. Epub 2005 Oct 27.
10
Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.糖醇相变法制备速崩片的评价
J Control Release. 2005 Jun 20;105(1-2):16-22. doi: 10.1016/j.jconrel.2005.01.018.